Showing results (141-150 of 511) with videos related to
Sort By:
Pageof 52
Annals of the Rheumatic Diseases|December 17, 2008
Stem cell transplantation: a treatment option for severe systemic sclerosis?J M van Laar, D Farge, A TyndallClinical and Experimental Rheumatology|November 6, 2014
A cautionary tale: dealing with missing data in clinical trials for rheumatic diseasesJ Song, W J Boscardin, D E Furst, et al.Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|December 26, 2001
Generation of TACT image slices using different reconstruction algorithms: effects on natural caries detectionM Abreu, D A Tyndall, J B LudlowClinical and Experimental Rheumatology|February 13, 2010
Tenofovir-induced osteomalaciaD P Wanner, A Tyndall, U A WalkerThe Journal of Rheumatology|August 1, 1987
Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blockerP A Rupp, S Mellinger, J Kohler, et al.The Journal of Rheumatology|June 1, 1984
Case control study of antibodies to ENA in progressive systemic sclerosis patientsD E Furst, M Obrodovic, E V Barnett, et al.Annals of the Rheumatic Diseases|December 1, 1984
Clinical and serological comparison of 17 chronic progressive systemic sclerosis (PSS) and 17 CREST syndrome patients matched for sex, age, and disease durationD E Furst, P J Clements, M Saab, et al.Journal of Endodontics|April 1, 1990
Digital subtraction radiography for detecting cortical and cancellous bone changes in the periapical regionD A Tyndall, S F Kapa, C P BagnellSchweizerische Medizinische Wochenschrift|January 15, 1999
[Chronic meningococcemia--a rare, but characteristic disease picture]H Grob, R Frei, A Tyndall, et al.Journal of Cellular Biochemistry|June 1, 1992
Wild-type murine p53 represses transcription from the murine c-myc promoter in a human glial cell lineK H Moberg, W A Tyndall, D J HallPageof 52